NCT01427920 - Comparison of Biphasic Insulin Aspart 30 Individually Adjusted by the Subject and the Trial Physician, Both Combined With Metformin in Subjects With Type 2 Diabetes | Biotech Hunter

Enrollment

348

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

biphasic insulin aspart 30

Administered subcutaneously (under the skin) using FlexPen® twice daily for 20 weeks. Directions for use were given to each subject at each dispensing visit. Subjects continued on their pre-trial metformin dose. Any previous basal insulin analogue and OAD (oral anti-diabetes drug) treatments (except for metformin) were discontinued.

Trial Locations (41)

1405

Novo Nordisk Investigational Site, Capital Federal

5000

Novo Nordisk Investigational Site, Córdoba

29006

Novo Nordisk Investigational Site, Málaga

46014

Novo Nordisk Investigational Site, Valencia

100034

Novo Nordisk Investigational Site, Beijing

110085

Novo Nordisk Investigational Site, New Delhi

116033

Novo Nordisk Investigational Site, Dalian

300211

Novo Nordisk Investigational Site, Tianjin

400007

Novo Nordisk Investigational Site, Mumbai

404000

Novo Nordisk Investigational Site, Chongqing

450052

Novo Nordisk Investigational Site, Zhengzhou

590001

Novo Nordisk Investigational Site, Belagavi

600028

Novo Nordisk Investigational Site, Chennai

641018

Novo Nordisk Investigational Site, Coimbatore

700054

Novo Nordisk Investigational Site, Kolkata

730000

Novo Nordisk Investigational Site, Lanzhou

C1056ABJ

Novo Nordisk Investigational Site, Capital Federal

B6740ELF

Novo Nordisk Investigational Site, Chacabuco

X5006IKK

Novo Nordisk Investigational Site, Córdoba

380 015

Novo Nordisk Investigational Site, Ahmedabad

695 032

Novo Nordisk Investigational Site, Thriruvananthapuram

15-404

Novo Nordisk Investigational Site, Bialystok

80-858

Novo Nordisk Investigational Site, Gdansk

90-242

Novo Nordisk Investigational Site, Lodz

59-300

Novo Nordisk Investigational Site, Lubin

41-709

Novo Nordisk Investigational Site, Ruda Śląska

81-756

Novo Nordisk Investigational Site, Sopot

00-911

Novo Nordisk Investigational Site, Warsaw

50-127

Novo Nordisk Investigational Site, Wroclaw

04001

Novo Nordisk Investigational Site, Almería

08540

Novo Nordisk Investigational Site, Centelles (Barcelona)

08430

Novo Nordisk Investigational Site, La Roca Del Vallés (Barcelona)

07014

Novo Nordisk Investigational Site, Palma de Mallorca

08500

Novo Nordisk Investigational Site, Vic (Barcelona)

DN9 2HY

Novo Nordisk Investigational Site, Doncaster

IP4 5PD

Novo Nordisk Investigational Site, Ipswich

M41 5SL

Novo Nordisk Investigational Site, Manchester

HA6 2RN

Novo Nordisk Investigational Site, Northwood

RG7 3SQ

Novo Nordisk Investigational Site, Reading

DN15 6HX

Novo Nordisk Investigational Site, Scunthorpe

CH63 4JY

Novo Nordisk Investigational Site, Wirral, Merseyside